136 related articles for article (PubMed ID: 36057899)
1. Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model.
Nishino H; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Singer BB; Hoffman RM; Bouvet M
Ann Surg Oncol; 2023 Jan; 30(1):618-625. PubMed ID: 36057899
[TBL] [Abstract][Full Text] [Related]
2. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
4. A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment.
Nishino H; Hollandsworth HM; Amirfakhri S; Tashiro Y; Yamamoto J; Turner MA; Lwin TM; Singer BB; Hoffman RM; Bouvet M
J Surg Res; 2021 Aug; 264():327-333. PubMed ID: 33848831
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
Metildi CA; Kaushal S; Hardamon CR; Snyder CS; Pu M; Messer KS; Talamini MA; Hoffman RM; Bouvet M
J Am Coll Surg; 2012 Jul; 215(1):126-35; discussion 135-6. PubMed ID: 22632917
[TBL] [Abstract][Full Text] [Related]
6. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
[TBL] [Abstract][Full Text] [Related]
7. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models.
Hiroshima Y; Maawy A; Zhang Y; Sato S; Murakami T; Yamamoto M; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
PLoS One; 2014; 9(6):e99977. PubMed ID: 24924955
[TBL] [Abstract][Full Text] [Related]
9. Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
Metildi CA; Felsen CN; Savariar EN; Nguyen QT; Kaushal S; Hoffman RM; Tsien RY; Bouvet M
Ann Surg Oncol; 2015; 22(6):2082-7. PubMed ID: 25319581
[TBL] [Abstract][Full Text] [Related]
10. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
[TBL] [Abstract][Full Text] [Related]
11. Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.
Maawy AA; Hiroshima Y; Zhang Y; Heim R; Makings L; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
PLoS One; 2015; 10(3):e0121989. PubMed ID: 25799218
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence-guided Surgery with Splenic Preservation Prevents Tumor Recurrence in an Orthotopic Nude-mouse Model of Human Pancreatic Cancer.
Hwang HK; Kang CM; Lee SH; Murakami T; Kiyuna T; Kim SH; Hoffman RM; Bouvet M
Anticancer Res; 2018 Feb; 38(2):665-670. PubMed ID: 29374688
[TBL] [Abstract][Full Text] [Related]
14. Anti-carcinoembryonic antigen-related cell adhesion molecule antibody for fluorescence visualization of primary colon cancer and metastases in patient-derived orthotopic xenograft mouse models.
Hollandsworth HM; Amirfakhri S; Filemoni F; Schmitt V; Wennemuth G; Schmidt A; Hoffman RM; Singer BB; Bouvet M
Oncotarget; 2020 Jan; 11(4):429-439. PubMed ID: 32064046
[TBL] [Abstract][Full Text] [Related]
15. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
[TBL] [Abstract][Full Text] [Related]
16. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
[TBL] [Abstract][Full Text] [Related]
17. Toward Curative Fluorescence-Guided Surgery of Pancreatic Cancer.
Bouvet M; Hoffman RM
Hepatogastroenterology; 2015 May; 62(139):715-22. PubMed ID: 26897960
[TBL] [Abstract][Full Text] [Related]
18. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery.
Gutowski M; Framery B; Boonstra MC; Garambois V; Quenet F; Dumas K; Scherninski F; Cailler F; Vahrmeijer AL; Pèlegrin A
Surg Oncol; 2017 Jun; 26(2):153-162. PubMed ID: 28577721
[TBL] [Abstract][Full Text] [Related]
19. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model.
Metildi CA; Kaushal S; Snyder CS; Hoffman RM; Bouvet M
J Surg Res; 2013 Jan; 179(1):87-93. PubMed ID: 23079571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
